Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
111OActivity of larotrectinib in TRK fusion lung cancerDrilon, A ; Kummar, S ; Moreno, V ; Patel, J ; Lassen, U ; Rosen, L ; Childs, B H ; Nanda, S ; Cox, M C ; Ku, N C ; Farago, A FAnnals of oncology, 2019-04, Vol.30 (Supplement_2) [Periódico revisado por pares]Oxford University PressTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
113OEntrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001Paz-Ares, L ; Doebele, R C ; Farago, A F ; Liu, S V ; Chawla, S P ; Tosi, D ; Blakely, C M ; Krauss, J C ; Sigal, D ; Bazhenova, L ; John, T ; Besse, B ; Wolf, J ; Seto, T ; Chow-Maneval, E ; Ye, C ; Simmons, B ; Demetri, G DAnnals of oncology, 2019-04, Vol.30 (Supplement_2) [Periódico revisado por pares]Oxford University PressTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
1181P Heterogeneity and prognostic diagnosis of KRAS-mutated population and KRAS G12C subtype among patients (pts) with advanced NSCLC (aNSCLC): A real-world study aided by machine learning approachesLoong, H.H.F. ; Liu, T. ; Pattipaka, T. ; Hong, R. ; Smith, T.W. ; Knoll, S.M. ; Pretre, V. ; Caparica Bitton, R. ; Ye, F. ; Farago, A.Annals of oncology, 2022-09, Vol.33, p.S1088 [Periódico revisado por pares]Texto completo disponível |
4 |
Material Type: Artigo
|
![]() |
1287P Efficacy and safety of entrectinib in locally advanced/metastatic ROS1 fusion-positive NSCLC: An updated integrated analysisKrebs, M.G. ; De Braud, F. ; Siena, S. ; Drilon, A. ; Doebele, R.C. ; Patel, M.R. ; Cho, B.C. ; Liu, S.V. ; Ahn, M-J. ; Chiu, C-H. ; Farago, A.F. ; Lin, C-C. ; Karapetis, C.S. ; Li, Y-C. ; Barlesi, F. ; Simmons, B. ; Pitcher, B. ; Dziadziuszko, R.Annals of oncology, 2020-09, Vol.31, p.S831-S833 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
1955P Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancerMcDermott, R. ; van Tilburg, C.M. ; Farago, A.F. ; Kummar, S. ; Tan, D.S.W. ; Albert, C.M. ; Berlin, J. ; Lassen, U.N. ; Doz, F. ; Geoerger, B. ; Mascarenhas, L. ; Federman, N. ; Reeves, J.A. ; Dima, L. ; Brega, N. ; De La Cuesta, E. ; Laetsch, T.W. ; Hong, D.S. ; Drilon, A.Annals of oncology, 2020-09, Vol.31, p.S1101-S1102 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
364O Intracranial efficacy of entrectinib in patients with NTRK fusion-positive solid tumours and baseline CNS metastasesJohn, T. ; Chiu, C-H. ; Cho, B.C. ; Fakih, M. ; Farago, A.F. ; Demetri, G.D. ; Goto, K. ; Doebele, R.C. ; Siena, S. ; Drilon, A. ; Patel, M.R. ; Liu, S.V. ; Ahn, M-J. ; Bazhenova, L. ; Overbeck, T.R. ; Nieva, J. ; Kim, S-W. ; Veronese, L. ; Day, B-M. ; De Braud, F.Annals of oncology, 2020-09, Vol.31, p.S397-S398 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
445PD - Durability of response with larotrectinib in adult and pediatric patients with TRK fusion cancerHyman, D.M. ; van Tilburg, C.M. ; Albert, C.M. ; Tan, D.S.W. ; Geoerger, B. ; Farago, A.F. ; Laetsch, T.W. ; Kummar, S. ; Doz, F. ; Lassen, U.N. ; DuBois, S.G. ; McDermott, R. ; Mascarenhas, L. ; Berlin, J.D. ; Rudzinski, E.R. ; Cox, M.C. ; Nanda, S. ; Childs, B.H. ; Drilon, A. ; Hong, D.S.Annals of oncology, 2019-10, Vol.30, p.v162-v163 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
445PDDurability of response with larotrectinib in adult and pediatric patients with TRK fusion cancerHyman, D M ; van Tilburg, C M ; Albert, C M ; Tan, D S W ; Geoerger, B ; Farago, A F ; Laetsch, T W ; Kummar, S ; Doz, F ; Lassen, U N ; DuBois, S G ; McDermott, R ; Mascarenhas, L ; Berlin, J D ; Rudzinski, E R ; Cox, M C ; Nanda, S ; Childs, B H ; Drilon, A ; Hong, D SAnnals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]Oxford University PressTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
540P Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapyLiu, S.V. ; De Braud, F. ; Drilon, A. ; Doebele, R.C. ; Patel, M.R. ; Cho, B.C. ; Ahn, M-J. ; Chiu, C-H. ; Farago, A.F. ; Goto, K. ; Lee, J. ; Ohe, Y. ; Ou, S-H.I. ; Cassier, P. ; Tan, D.S.W. ; Otterson, G.A. ; Veronese, L. ; Osborne, S. ; Simmons, B. ; Siena, S.Annals of oncology, 2020-09, Vol.31, p.S472-S473 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
10 |
Material Type: Livro
|
![]() |
Abrasive methods engineeringFrancis T. FaragoNew York Industrial Press 1980Item não circula. Consulte sua biblioteca.(Acessar) |